Logo image of CARM.PA

CARMILA (CARM.PA) Stock Fundamental Analysis

Europe - EPA:CARM - FR0010828137 - REIT

17.02 EUR
-0.1 (-0.58%)
Last: 9/19/2025, 7:00:00 PM
Fundamental Rating

6

Taking everything into account, CARM scores 6 out of 10 in our fundamental rating. CARM was compared to 40 industry peers in the Diversified REITs industry. CARM has an excellent profitability rating, but there are some minor concerns on its financial health. CARM may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

CARM had positive earnings in the past year.
CARM had a positive operating cash flow in the past year.
Of the past 5 years CARM 4 years were profitable.
Each year in the past 5 years CARM had a positive operating cash flow.
CARM.PA Yearly Net Income VS EBIT VS OCF VS FCFCARM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

CARM's Return On Assets of 5.24% is amongst the best of the industry. CARM outperforms 95.00% of its industry peers.
CARM has a Return On Equity of 10.53%. This is amongst the best in the industry. CARM outperforms 92.50% of its industry peers.
With an excellent Return On Invested Capital value of 4.91%, CARM belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CARM is in line with the industry average of 3.43%.
The last Return On Invested Capital (4.91%) for CARM is above the 3 year average (3.52%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.24%
ROE 10.53%
ROIC 4.91%
ROA(3y)2.69%
ROA(5y)1.6%
ROE(3y)5.18%
ROE(5y)3.03%
ROIC(3y)3.52%
ROIC(5y)3.08%
CARM.PA Yearly ROA, ROE, ROICCARM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

1.3 Margins

CARM has a better Profit Margin (64.32%) than 70.00% of its industry peers.
CARM's Profit Margin has improved in the last couple of years.
CARM's Operating Margin of 87.92% is amongst the best of the industry. CARM outperforms 92.50% of its industry peers.
CARM's Operating Margin has improved in the last couple of years.
CARM's Gross Margin of 72.59% is in line compared to the rest of the industry. CARM outperforms 47.50% of its industry peers.
CARM's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 87.92%
PM (TTM) 64.32%
GM 72.59%
OM growth 3Y17.79%
OM growth 5Y7.19%
PM growth 3Y11.44%
PM growth 5Y20.21%
GM growth 3Y2.7%
GM growth 5Y-0.75%
CARM.PA Yearly Profit, Operating, Gross MarginsCARM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100 150 200

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CARM is destroying value.
Compared to 1 year ago, CARM has less shares outstanding
The number of shares outstanding for CARM has been increased compared to 5 years ago.
Compared to 1 year ago, CARM has an improved debt to assets ratio.
CARM.PA Yearly Shares OutstandingCARM.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
CARM.PA Yearly Total Debt VS Total AssetsCARM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 0.97, we must say that CARM is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.97, CARM perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
The Debt to FCF ratio of CARM is 8.32, which is on the high side as it means it would take CARM, 8.32 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 8.32, CARM belongs to the best of the industry, outperforming 92.50% of the companies in the same industry.
A Debt/Equity ratio of 0.77 indicates that CARM is somewhat dependend on debt financing.
CARM has a Debt to Equity ratio of 0.77. This is in the lower half of the industry: CARM underperforms 62.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 8.32
Altman-Z 0.97
ROIC/WACC0.98
WACC5.03%
CARM.PA Yearly LT Debt VS Equity VS FCFCARM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 0.74 indicates that CARM may have some problems paying its short term obligations.
CARM has a better Current ratio (0.74) than 65.00% of its industry peers.
A Quick Ratio of 0.74 indicates that CARM may have some problems paying its short term obligations.
With a decent Quick ratio value of 0.74, CARM is doing good in the industry, outperforming 67.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.74
Quick Ratio 0.74
CARM.PA Yearly Current Assets VS Current LiabilitesCARM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

CARM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 572.32%, which is quite impressive.
Measured over the past years, CARM shows a very strong growth in Earnings Per Share. The EPS has been growing by 22.86% on average per year.
Looking at the last year, CARM shows a quite strong growth in Revenue. The Revenue has grown by 17.64% in the last year.
Measured over the past years, CARM shows a small growth in Revenue. The Revenue has been growing by 2.93% on average per year.
EPS 1Y (TTM)572.32%
EPS 3Y18.46%
EPS 5Y22.86%
EPS Q2Q%46.39%
Revenue 1Y (TTM)17.64%
Revenue growth 3Y5.68%
Revenue growth 5Y2.93%
Sales Q2Q%16.35%

3.2 Future

The Earnings Per Share is expected to grow by 5.04% on average over the next years.
CARM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.56% yearly.
EPS Next Y8.04%
EPS Next 2Y5.83%
EPS Next 3Y5.04%
EPS Next 5YN/A
Revenue Next Year11.46%
Revenue Next 2Y6.76%
Revenue Next 3Y3.56%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CARM.PA Yearly Revenue VS EstimatesCARM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
CARM.PA Yearly EPS VS EstimatesCARM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

9

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 6.84, the valuation of CARM can be described as very cheap.
Based on the Price/Earnings ratio, CARM is valued cheaply inside the industry as 97.50% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 27.38, CARM is valued rather cheaply.
A Price/Forward Earnings ratio of 9.02 indicates a reasonable valuation of CARM.
CARM's Price/Forward Earnings ratio is rather cheap when compared to the industry. CARM is cheaper than 82.50% of the companies in the same industry.
CARM is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.86, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 6.84
Fwd PE 9.02
CARM.PA Price Earnings VS Forward Price EarningsCARM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CARM is valued cheaper than 95.00% of the companies in the same industry.
CARM's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CARM is cheaper than 87.50% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.15
EV/EBITDA 10.45
CARM.PA Per share dataCARM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CARM has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)0.85
PEG (5Y)0.3
EPS Next 2Y5.83%
EPS Next 3Y5.04%

6

5. Dividend

5.1 Amount

CARM has a Yearly Dividend Yield of 7.30%, which is a nice return.
Compared to an average industry Dividend Yield of 5.58, CARM pays a better dividend. On top of this CARM pays more dividend than 87.50% of the companies listed in the same industry.
CARM's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 7.3%

5.2 History

The dividend of CARM decreases each year by -4.29%.
Dividend Growth(5Y)-4.29%
Div Incr Years0
Div Non Decr Years0
CARM.PA Yearly Dividends per shareCARM.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2024 0.2 0.4 0.6 0.8

5.3 Sustainability

CARM pays out 50.04% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP50.04%
EPS Next 2Y5.83%
EPS Next 3Y5.04%
CARM.PA Yearly Income VS Free CF VS DividendCARM.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M
CARM.PA Dividend Payout.CARM.PA Dividend Payout, showing the Payout Ratio.CARM.PA Dividend Payout.PayoutRetained Earnings

CARMILA

EPA:CARM (9/19/2025, 7:00:00 PM)

17.02

-0.1 (-0.58%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)07-23 2025-07-23
Earnings (Next)10-23 2025-10-23
Inst Owners29.64%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap2.40B
Analysts78.67
Price Target20.48 (20.33%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.3%
Yearly Dividend1.21
Dividend Growth(5Y)-4.29%
DP50.04%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.3%
PT rev (3m)1.1%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)1.01%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.16%
Valuation
Industry RankSector Rank
PE 6.84
Fwd PE 9.02
P/S 4.38
P/FCF 7.15
P/OCF 7.09
P/B 0.72
P/tB 0.72
EV/EBITDA 10.45
EPS(TTM)2.49
EY14.63%
EPS(NY)1.89
Fwd EY11.09%
FCF(TTM)2.38
FCFY13.99%
OCF(TTM)2.4
OCFY14.11%
SpS3.89
BVpS23.74
TBVpS23.73
PEG (NY)0.85
PEG (5Y)0.3
Profitability
Industry RankSector Rank
ROA 5.24%
ROE 10.53%
ROCE 7.65%
ROIC 4.91%
ROICexc 5%
ROICexgc 5%
OM 87.92%
PM (TTM) 64.32%
GM 72.59%
FCFM 61.25%
ROA(3y)2.69%
ROA(5y)1.6%
ROE(3y)5.18%
ROE(5y)3.03%
ROIC(3y)3.52%
ROIC(5y)3.08%
ROICexc(3y)3.79%
ROICexc(5y)3.29%
ROICexgc(3y)3.79%
ROICexgc(5y)3.29%
ROCE(3y)5.48%
ROCE(5y)4.8%
ROICexcg growth 3Y20.72%
ROICexcg growth 5Y9%
ROICexc growth 3Y20.74%
ROICexc growth 5Y9.01%
OM growth 3Y17.79%
OM growth 5Y7.19%
PM growth 3Y11.44%
PM growth 5Y20.21%
GM growth 3Y2.7%
GM growth 5Y-0.75%
F-Score5
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 8.32
Debt/EBITDA 5.3
Cap/Depr 68.54%
Cap/Sales 0.52%
Interest Coverage 3.91
Cash Conversion 69.65%
Profit Quality 95.22%
Current Ratio 0.74
Quick Ratio 0.74
Altman-Z 0.97
F-Score5
WACC5.03%
ROIC/WACC0.98
Cap/Depr(3y)129.75%
Cap/Depr(5y)102.72%
Cap/Sales(3y)1.8%
Cap/Sales(5y)1.14%
Profit Quality(3y)3321.64%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)572.32%
EPS 3Y18.46%
EPS 5Y22.86%
EPS Q2Q%46.39%
EPS Next Y8.04%
EPS Next 2Y5.83%
EPS Next 3Y5.04%
EPS Next 5YN/A
Revenue 1Y (TTM)17.64%
Revenue growth 3Y5.68%
Revenue growth 5Y2.93%
Sales Q2Q%16.35%
Revenue Next Year11.46%
Revenue Next 2Y6.76%
Revenue Next 3Y3.56%
Revenue Next 5YN/A
EBIT growth 1Y69.71%
EBIT growth 3Y24.48%
EBIT growth 5Y10.33%
EBIT Next Year6.57%
EBIT Next 3Y4.26%
EBIT Next 5Y2.86%
FCF growth 1Y20.89%
FCF growth 3Y4.44%
FCF growth 5Y0.82%
OCF growth 1Y20.76%
OCF growth 3Y4.74%
OCF growth 5Y1.02%